Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein

Clinical Chemistry

Volumn 50, Issue 6, 2004, Pages 988-995

  Chen, Zeliang ^a   Pei, Decui ^a   Jiang, Lingxiao ^a   Song, Yajun ^a   Wang, Jin ^a   Wang, Hongxia ^a   Zhou, Dongsheng ^a   Zhai, Junhui ^a   Du, Zongmin ^a   Li, Bei ^a   Qiu, Maofeng ^a   Han, Yanping ^a   Guo, Zhaobiao ^a   Yang, Ruifu ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; COMPLEMENTARY DNA; EPITOPE; NUCLEOCAPSID PROTEIN; PEPTIDE FRAGMENT; VIRUS ANTIBODY;

ANTIGENICITY; ARTICLE; EPITOPE MAPPING; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; MOLECULAR CLONING; MOLECULAR PROBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN PURIFICATION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

ANTIGENS, VIRAL; CLONING, MOLECULAR; DNA, COMPLEMENTARY; EPITOPES; ESCHERICHIA COLI; HUMANS; NUCLEOCAPSID PROTEINS; PROTEIN ARRAY ANALYSIS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

CORONAVIRUS; ESCHERICHIA COLI; SARS CORONAVIRUS;

EID: 2642516339     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.031096     Document Type: Article

References (27)

1. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
2. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
3. Falsey AR, Walsh EE. Novel coronavirus and severe acute respiratory syndrome. Lancet 2003;361:1312-3.
4. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, et al. The genome sequence of the SARS-associated coronavirus. Science 2003;300:1399-404.
5. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-9.
6. Enserink M. SARS in China. China's missed chance. Science 2003;301:294-6.
7. Narayanan K, Makino S. Characterization of nucleocapsid-M protein interaction in murine coronavirus. Adv Exp Med Biol 2001;494:577-82.
8. Narayanan K, Maeda A, Maeda J, Makino S. Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol 2000;74:8127-34.
9. Lai MM. Coronavirus: organization, replication and expression of genome. Annu Rev Microbiol 1990;44:303-33.
10. Xu HY, Lim KP, Shen S, Liu DX. Further identification and characterization of novel intermediate and mature cleavage products released from the ORF 1b region of the avian coronavirus infectious bronchitis virus 1a/1b polyprotein. Virology 2001;288:212-22.
11. Tahara SM, Dietlin TA, Bergmann CC, Nelson GW, Kyuwa S, Anthony RP, et al. Coronavirus translational regulation: leader affects mRNA efficiency. Virology 1994;202:621-30.
12. Nelson GW, Stohlman SA, Tahara SM. High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA. J Gen Virol 2000;81:181-8.
13. Seo SH, Wang L, Smith R, Collisson EW. The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection. J Virol 1997;71:7889-94.
14. Shi Y, Yi Y, Li P, Kuang T, Li L, Dong M, et al. Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay. J Clin Microbiol 2003;41:5781-2.
15. Wang J, Wen J, Li J, Yin J, Zhu Q, Wang H, et al. Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin Chem 2003;49:1989-96.
16. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
17. Wang J, Ji J, Ye J, Zhao X, Wen J, Li W, et al. The structure analysis and antigenicity study of the N protein of SARS-CoV. Genomics Proteomics Bioinformatics 2003;1:145-54.
18. de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol 2000;18:989-94.
19. Knezevic V, Leethanakul C, Bichsel VE, Worth JM, Prabhu VV, Gutkind JS, et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001;1:1271-8.
20. Wilson DS, Nock S. Recent developments in protein microarray technology. Angew Chem Int Ed Engl 2003;42:494-500.
21. Haab BB. Advances in protein microarray technology for protein expression and interaction profiling. Curr Opin Drug Discov Dev 2001;4:116-23.
22. Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P, et al. Global analysis of protein activities using proteome chips. Science 2001;293:2101-5.
23. Parker MM, Masters PS. Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein. Virology 1990;179:463-8.
24. Cologna R, Spagnolo JF, Hogue BG. Identification of nucleocapsid binding sites within coronavirus-defective genomes. Virology 2000;277:235-49.
25. Kuo L, Masters PS. Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J Virol 2002;76:4987-99.
26. Shi L, Rui W, Lee M. [Preliminary analysis of the structure and function of SARS putative nucleocapsid protein]. http://cmbi.bjmu.edu.cn/cmbidata/sars/ html/41.pdf (accessed June 2003).
27. Shi L, Rui W, Lee M. [Nuclear targeting sequence in SARS nucleocapsid protein]. http://cmbi.bjmu.edu.cn/cmbidata/sars/html/10.pdf (accessed June 2003).